| Phase 3 |
| NCT05302284 |
A Study of RC48-ADC Combined With Toripalimab For First-line Treatment of Urothelial… |
Urothelial Carcinoma |
Recruiting |
| NCT07315750 |
A Study of Disitamab Vedotin Combined With Trastuzumab and Tislelizumab Versus… |
Gastric Carcinoma |
Recruiting |
| NCT07249632 |
A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG) |
Myasthenia Gravis, Ocular |
Recruiting |
| NCT07416474 |
RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy… |
Non-Small Cell Lung Cancer |
Recruiting |
| NCT06944496 |
A Study of Disitamab Vedotin Combined With Tislelizumab and Chemotherapy Versus… |
Gastric Carcinoma |
Not Yet Recruiting |
| NCT05799287 |
A Study of Telitacicept for IgA Nephropathy (TELIGAN) |
Primary IgA Nephropathy |
Active, Not Recruiting |
| NCT07495033 |
Phase III Clinical Trial of Telitacicept Injection in the Treatment of Patients With… |
CTD-ILD |
Not Yet Recruiting |
| Phase 2/3 |
| NCT06221748 |
DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and… |
Gastric Cancer |
Recruiting |
| NCT07462143 |
A Phase Ⅱ/Ⅲ Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or… |
Colorectal (Colon or Rectal) Cancer |
Recruiting |
| NCT05980481 |
A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic… |
Gastric Cancer |
Active, Not Recruiting |
| Phase 2 |
| NCT05943379 |
RC48-ADC in Combination With Gemcitabine in High Risk NMIBC Subjects |
NMIBC |
Recruiting |
| NCT06155383 |
Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal… |
Gastric Cancer |
Recruiting |
| NCT06155396 |
A Study of RC48-ADC Combination With Zimberelimab Injection Therapies at Least First-line… |
Cervical Cancer |
Recruiting |
| NCT06227117 |
Neoadjuvant Study of DV in Combination Toripalimab or Sequence Chemotherapy in… |
Breast Cancer |
Recruiting |
| NCT06389006 |
To Evaluate the Efficacy and Safety of Disitamab Vedotin Combined With Toripalimab… |
Breast Cancer |
Recruiting |
| NCT05680480 |
A Study of Telitacicept in Lupus Nephritis |
Lupus Nephritis |
Recruiting |
| NCT06642545 |
Efficacy and Safety Study of Disitamab Vedotin + RC148 vs. Albumin-Paclitaxone ±… |
Breast Cancer |
Recruiting |
| NCT06962865 |
A Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment… |
Non-Small Cell Lung Cancer |
Recruiting |
| NCT06178159 |
DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With… |
Breast Cancer |
Recruiting |
| Phase 1/2 |
| NCT05821933 |
RC108 Combine With Furmonertinib With/Without Toripalimab in Patients With EGFR-mutated… |
NSCLC |
Recruiting |
| NCT06378242 |
To Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravesical Instiliations of… |
High-risk Non-muscle Invasive Bladder Cancer |
Recruiting |
| NCT06016062 |
A Study of RC148 As a Single Agent and Combination Therapy in Patients with Locally… |
Solid Tumor |
Recruiting |
| NCT05205850 |
A Study of RC118 in Patients with Locally Advanced Unresectable or Metastatic Malignant… |
Advanced Solid Tumor |
Recruiting |
| NCT06038396 |
A Study of RC118 Plus Toripalimab / RC148 in Patients with Locally Advanced Unresectable… |
Advanced Solid Tumor |
Recruiting |
| NCT07105215 |
A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment… |
Solid Tumors |
Recruiting |